BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1815 related articles for article (PubMed ID: 26062653)

  • 21. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
    Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-1271 inhibits migration, invasion and epithelial-mesenchymal transition by targeting ZEB1 and TWIST1 in pancreatic cancer cells.
    Liu H; Wang H; Liu X; Yu T
    Biochem Biophys Res Commun; 2016 Apr; 472(2):346-52. PubMed ID: 26940738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening of acetaminophen-induced alterations in epithelial-to-mesenchymal transition-related expression of microRNAs in a model of stem-like triple-negative breast cancer cells: The possible functional impacts.
    Afshar E; Hashemi-Arabi M; Salami S; Peirouvi T; Pouriran R
    Gene; 2019 Jun; 702():46-55. PubMed ID: 30898700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer.
    Koleckova M; Ehrmann J; Bouchal J; Janikova M; Brisudova A; Srovnal J; Staffova K; Svoboda M; Slaby O; Radova L; Vomackova K; Melichar B; Veverkova L; Kolar Z
    Sci Rep; 2021 Mar; 11(1):5145. PubMed ID: 33664322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oridonin inhibition and miR‑200b‑3p/ZEB1 axis in human pancreatic cancer.
    Gui Z; Luo F; Yang Y; Shen C; Li S; Xu J
    Int J Oncol; 2017 Jan; 50(1):111-120. PubMed ID: 27878247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arrestin Domain Containing 3 Reverses Epithelial to Mesenchymal Transition and Chemo-Resistance of TNBC Cells by Up-Regulating Expression of miR-200b.
    Soung YH; Chung H; Yan C; Ju J; Chung J
    Cells; 2019 Jul; 8(7):. PubMed ID: 31295851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-200b-3p suppresses epithelial-mesenchymal transition and inhibits tumor growth of glioma through down-regulation of ERK5.
    Wu J; Cui H; Zhu Z; Wang L
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1158-64. PubMed ID: 27545608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2.
    Lv ZD; Yang DX; Liu XP; Jin LY; Wang XG; Yang ZC; Liu D; Zhao JJ; Kong B; Li FN; Wang HB
    Cell Physiol Biochem; 2017; 44(5):1785-1795. PubMed ID: 29216628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.
    Li X; Roslan S; Johnstone CN; Wright JA; Bracken CP; Anderson M; Bert AG; Selth LA; Anderson RL; Goodall GJ; Gregory PA; Khew-Goodall Y
    Oncogene; 2014 Jul; 33(31):4077-88. PubMed ID: 24037528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR302a-3p May Modulate Renal Epithelial-Mesenchymal Transition in Diabetic Kidney Disease by Targeting ZEB1.
    Tang WB; Zheng L; Yan R; Yang J; Ning J; Peng L; Zhou Q; Chen L
    Nephron; 2018; 138(3):231-242. PubMed ID: 29227974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteasome inhibitor-resistant cells cause EMT-induction via suppression of E-cadherin by miR-200 and ZEB1.
    Asakura T; Yamaguchi N; Ohkawa K; Yoshida K
    Int J Oncol; 2015 May; 46(5):2251-60. PubMed ID: 25738863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
    Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
    Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer.
    Yu Y; Zhao Y; Sun XH; Ge J; Zhang B; Wang X; Cao XC
    Oncotarget; 2015 Oct; 6(33):34423-36. PubMed ID: 26460733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-200 (miR-200) cluster regulation by achaete scute-like 2 (Ascl2): impact on the epithelial-mesenchymal transition in colon cancer cells.
    Tian Y; Pan Q; Shang Y; Zhu R; Ye J; Liu Y; Zhong X; Li S; He Y; Chen L; Zhao J; Chen W; Peng Z; Wang R
    J Biol Chem; 2014 Dec; 289(52):36101-15. PubMed ID: 25371200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The microRNAs miR-200b-3p and miR-429-5p target the LIMK1/CFL1 pathway to inhibit growth and motility of breast cancer cells.
    Li D; Wang H; Song H; Xu H; Zhao B; Wu C; Hu J; Wu T; Xie D; Zhao J; Shen Q; Fang L
    Oncotarget; 2017 Oct; 8(49):85276-85289. PubMed ID: 29156719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
    Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A
    BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. microRNA miR-200b affects proliferation, invasiveness and stemness of endometriotic cells by targeting ZEB1, ZEB2 and KLF4.
    Eggers JC; Martino V; Reinbold R; Schäfer SD; Kiesel L; Starzinski-Powitz A; Schüring AN; Kemper B; Greve B; Götte M
    Reprod Biomed Online; 2016 Apr; 32(4):434-45. PubMed ID: 26854065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
    Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
    Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-544a induces epithelial-mesenchymal transition through the activation of WNT signaling pathway in gastric cancer.
    Yanaka Y; Muramatsu T; Uetake H; Kozaki K; Inazawa J
    Carcinogenesis; 2015 Nov; 36(11):1363-71. PubMed ID: 26264654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor suppressor miR-128-3p inhibits metastasis and epithelial-mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer.
    Zhao L; Li R; Xu S; Li Y; Zhao P; Dong W; Liu Z; Zhao Q; Tan B
    Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):171-180. PubMed ID: 29329360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 91.